Palmieri Tina L, Holmes James H, Arnoldo Brett, Peck Michael, Potenza Bruce, Cochran Amalia, King Booker T, Dominic William, Cartotto Robert, Bhavsar Dhaval, Kemalyan Nathan, Tredget Edward, Stapelberg Francois, Mozingo David, Friedman Bruce, Greenhalgh David G, Taylor Sandra L, Pollock Brad H
*Department of Surgery, University of California Davis and Shriners Hospital for Children Northern California, Sacramento, CA †Department of Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC ‡Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX §Department of Surgery, The Arizona Burn Center, The Arizona Burn Center and University of Arizona College of Medicine, Phoenix, AZ ¶Department of Surgery, University of California San Diego, San Diego, CA ||Department of Surgery, University of Utah, Salt Lake City, UT **Department of Surgery, Institute of Surgical Research, San Antonio, TX ††Department of Surgery, Community Regional Medical Center, Fresno, CA ‡‡Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON, Canada §§Department of Surgery, Kansas University Medical Center, Kansas City, KS ¶¶Department of Surgery, Oregon Burn Center, Portland, OR ||||Department of Surgery, University of Alberta, Edmonton, AB, Canada ***Department of Anesthesia, New Zealand National Burn Centre, Middlemore Hospital, Middlemore, New Zealand †††Department of Surgery, University of Florida Health Science Center, Gainesville, FL ‡‡‡Department of Surgery, JM Still Burn Center, Augusta, GA §§§Department of Public Health Sciences, University of California Davis, Sacramento, CA.
Ann Surg. 2017 Oct;266(4):595-602. doi: 10.1097/SLA.0000000000002408.
Our objective was to compare outcomes of a restrictive to a liberal red cell transfusion strategy in 20% or more total body surface area (TBSA) burn patients. We hypothesized that the restrictive group would have less blood stream infection (BSI), organ dysfunction, and mortality.
Patients with major burns have major (>1 blood volume) transfusion requirements. Studies suggest that a restrictive blood transfusion strategy is equivalent to a liberal strategy. However, major burn injury is precluded from these studies. The optimal transfusion strategy in major burn injury is thus needed but remains unknown.
This prospective randomized multicenter trial block randomized patients to a restrictive (hemoglobin 7-8 g/dL) or liberal (hemoglobin 10-11 g/dL) transfusion strategy throughout hospitalization. Data collected included demographics, infections, transfusions, and outcomes.
Eighteen burn centers enrolled 345 patients with 20% or more TBSA burn similar in age, TBSA burn, and inhalation injury. A total of 7054 units blood were transfused. The restrictive group received fewer blood transfusions: mean 20.3 ± 32.7 units, median = 8 (interquartile range: 3, 24) versus mean 31.8 ± 44.3 units, median = 16 (interquartile range: 7, 40) in the liberal group (P < 0.0001, Wilcoxon rank sum). BSI incidence, organ dysfunction, ventilator days, and time to wound healing (P > 0.05) were similar. In addition, there was no 30-day mortality difference: 9.5% restrictive versus 8.5% liberal (P = 0.892, χ test).
A restrictive transfusion strategy halved blood product utilization. Although the restrictive strategy did not decrease BSI, mortality, or organ dysfunction in major burn injury, these outcomes were no worse than the liberal strategy (Clinicaltrials.gov identifier NCT01079247).
我们的目的是比较在总体表面积(TBSA)烧伤达20%或更多的患者中,限制性红细胞输血策略与宽松输血策略的效果。我们假设限制性输血组的血流感染(BSI)、器官功能障碍及死亡率更低。
严重烧伤患者有大量(超过1个血容量)的输血需求。研究表明,限制性输血策略等同于宽松输血策略。然而,这些研究未纳入严重烧伤患者。因此,严重烧伤损伤的最佳输血策略尚需确定,但目前仍不清楚。
这项前瞻性随机多中心试验采用区组随机化方法,将患者在整个住院期间随机分为限制性(血红蛋白7 - 8g/dL)或宽松(血红蛋白10 - 11g/dL)输血策略组。收集的数据包括人口统计学资料、感染情况、输血情况及转归。
18个烧伤中心纳入了345例TBSA烧伤达20%或更多的患者,这些患者在年龄、TBSA烧伤面积及吸入性损伤方面相似。共输注了7054单位血液。限制性输血组输注的血液较少:平均20.3±32.7单位,中位数 = 8(四分位间距:3,24),而宽松输血组平均为31.8±44.3单位,中位数 = 16(四分位间距:7,40)(P < 0.0001,Wilcoxon秩和检验)。BSI发生率、器官功能障碍、机械通气天数及伤口愈合时间(P > 0.05)相似。此外,30天死亡率无差异:限制性输血组为9.5%,宽松输血组为8.5%(P = 0.892,χ检验)。
限制性输血策略使血液制品的使用量减半。虽然限制性输血策略在严重烧伤损伤中未降低BSI、死亡率或器官功能障碍,但这些结果并不比宽松输血策略差(Clinicaltrials.gov标识符NCT01079247)。